Correlation of Pre- and Post-operative Cancer Imaging Techniques

Lung Cancer Clinical Trial

Official title:

PET-PATH: Investigation of New Medical Imaging Techniques for Improving Lung Cancer Treatment

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04776291
• Other study ID #: UEC20/51
• Status: Recruiting
• Phase: N/A
• Start date: June 15, 2022
• Est. completion date: June 1, 2024

Study information

• Verified date: May 2023
• Source: University of Strathclyde
• Contact: Matthew R M Gil, MSc
• Phone: +447751152132
• Email: matthew.gil[@]strath.ac.uk
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Various imaging modalities are used in medical diagnosis such as MRI, CT and PET. The images are sometimes acquired at different times and in different body positions, and thus need to be aligned for precise diagnosis and treatment planning. Different image modalities provide complementary information about the anatomical structure under study. Image registration techniques enable multimodality images to be projected onto a common coordinate system, so that these images can be aligned and spatial correspondences can be established between the images.

This research project aims to investigate the information provided by functional PET and CT images about the tumour environment in lung cancer patients by registering functional PET and CT images with the pathology images acquired from the same patient. On identification of specific region of interest on the functional imaging the investigators will then be able to interrogate the tumour biology. In many cancers, the tumour environment is usually composed of a heterogeneous mass of tissue. The discrimination and classification of the carcinoma substructures is of paramount importance in the radiotherapy planning stage, as a given treatment may be more or less suitable depending on the local characteristics of the tumour. For instance, in hypoxic regions (areas inside the tumour with very low oxygen supply), radiotherapy performs poorly and strategies to intensify treatment to those areas could be investigated.

This project will develop a framework for automatic registration of pathology images, which are taken from a surgically extracted lung tumour, with the corresponding PET/CT scan acquired from the patient before surgery. The registration of these images is essential for the evaluation of the performance of different PET radiotracers.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 10
• Est. completion date: June 1, 2024
• Est. primary completion date: May 1, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 99 Years

Eligibility

Inclusion Criteria:

• Patient diagnosed with primary lung cancer and are due to undergo curative surgical resection of the tumour

• At least one of the tumour's major axes is larger than 30mm.

• The main volume of the tumour is located within the lung tissue.

• Tumour is identified primarily as single mass lesion.

Exclusion Criteria:

• Patient is under 18 years old.

Related Conditions & MeSH terms

• Lung Cancer
• Lung Neoplasms

Intervention

Radiation:
• 4D PET-CT Scan
The recruited patients will have a 4d PET-CT scan that is additional to the usual care.

Locations

Country	Name	City	State
United Kingdom	West of Scotland Pet Centre	Glasgow

Sponsors (2)

Lead Sponsor	Collaborator
University of Strathclyde	NHS Greater Glasgow and Clyde

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	4D PET-CT images aquired	The patent needs to have one 4D PET-CT scan, this is the only requirement in the study as the surgery they will undertake is part of standard care.	up to 4 weeks after the PET-CT image is taken.